AUTHENTICATED
`us. GOVERNMENT
`INleMATIaN
`GPO
`
`22069
`Federal Register/Vol. 86, No. 78/ Monday, April 26, 2021/Notices
`
`public hearing to be held in connection
`therewith was given by posting copies
`of the notice in the Office of the
`
`Secretary, U.S. International Trade
`Conunission, Washington, DC, and by
`publishing the notice in the Federal
`Register on November 18, 2020 (85 FR
`73511). In light of the restrictions on
`access to the Commission building due
`to the COVID—19 pandemic, the
`Connnission conducted its hearing
`through written testimony and video
`conference on March 2, 2021. All
`persons who requested the opportunity
`were permitted to participate.
`The Commission made these
`
`determinations pursuant to §§ 705(b)
`and 735(b) of the Act (19 U.S.C.
`1671d(b) and 19 U.S.C. 1673d(b)). It
`completed and filed its determinations
`in these investigations on April 20,
`2021. The views of the Commission are
`contained in USITC Publication 5182
`
`(April 2021), entitled Common Alloy
`Aluminum Sheet from Bahrain, Brazil,
`Croatia, Egypt, Germany, India,
`Indonesia, Italy, Oman, Romania,
`Serbia, Slovenia, South Africa, Spain,
`Taiwan, and Turkey: Investigation Nos.
`701—TA—639 and 641—642 and 731—TA—
`1475—1479, 1481—1483 and 1485—1492
`(Final).
`
`By order of the Commission.
`Dated: April 20, 2021.
`Lisa Barton,
`Secretary to the Commission.
`[FR Doc. 2021—08572 Filed 4—23—21; 8:45 am]
`BILLING cooE 7020-02-P
`
`INTERNATIONAL TRADE
`COMMISSION
`
`Notice of Receipt of Complaint;
`Solicitation of Comments Relating to
`the Public Interest
`
`AGENCY: U.S. International Trade
`Commission.
`ACTION: Notice.
`
`SUMMARY: Notice is hereby given that
`the U.S. International Trade
`
`Conunission has received a complaint
`entitled Certain Wearable Electronic
`
`Devices with ECG Capability and
`Components Thereof, DN 3545; the
`Conunission is soliciting comments on
`any public interest issues raised by the
`complaint or complainant’s filing
`pursuant to the Commission’s Rules of
`Practice and Procedure.
`FOR FURTHER INFORMATION CONTACT: Lisa
`
`R. Barton, Secretary to the Commission,
`U.S. International Trade Commission,
`500 E Street SW, Washington, DC
`20436, telephone (202) 205—2000. The
`public version of the complaint can be
`accessed on the Commission’s
`
`Electronic Document Information
`
`System (EDIS) at https://edis.usitc.gov.
`For help accessing EDIS, please email
`EDIS3HeIp@usitc.gov.
`General information concerning the
`Commission may also be obtained by
`accessing its internet server at United
`States International Trade Commission
`
`(USITC) at https://www.usitc.gov. The
`public record for this investigation may
`be viewed on the Commission’s
`Electronic Document Information
`
`System (EDIS) at https://edis.usitc.gov.
`Hearing-impaired persons are advised
`that information on this matter can be
`
`obtained by contacting the
`Commission’s TDD terminal on (202)
`205—1810.
`
`SUPPLEMENTARY INFORMATION: The
`
`Commission has received a complaint
`and a submission pursuant to § 210.8(b)
`of the Commission’s Rules of Practice
`and Procedure filed on behalf of
`
`AliveCor, Inc. on April 20, 2021. The
`complaint alleges violations of section
`337 of the Tariff Act of 1930 (19 U.S.C.
`1337) in the importation into the United
`States, the sale for importation, and the
`sale within the United States after
`
`importation of certain wearable
`electronic devices with ECG capability
`and components thereof. The
`complainant names as respondent:
`Apple Inc. of Cupertino, CA. The
`complainant requests that the
`Commission issue a limited exclusion
`order, cease and desist orders, and
`impose a bond upon respondent alleged
`infringing articles during the 60-day
`Presidential review period pursuant to
`19 U.S.C. 1337(j).
`Proposed respondents, other
`interested parties, and members of the
`public are invited to file comments on
`any public interest issues raised by the
`complaint or § 210.8(b) filing.
`Comments should address whether
`
`issuance of the relief specifically
`requested by the complainant in this
`investigation would affect the public
`health and welfare in the United States,
`competitive conditions in the United
`States economy, the production of like
`or directly competitive articles in the
`United States, or United States
`consumers.
`
`In particular, the Commission is
`interested in comments that:
`
`(i) Explain how the articles
`potentially subject to the requested
`remedial orders are used in the United
`States;
`(ii) identify any public health, safety,
`or welfare concerns in the United States
`
`relating to the requested remedial
`orders;
`(iii) identify like or directly
`competitive articles that complainant,
`
`its licensees, or third parties make in the
`United States which could replace the
`subject articles if they were to be
`excluded;
`(iv) indicate whether complainant,
`complainant’s licensees, and/or third
`party suppliers have the capacity to
`replace the volume of articles
`potentially subject to the requested
`exclusion order and/or a cease and
`
`desist order within a commercially
`reasonable time; and
`(v) explain how the requested
`remedial orders would impact United
`States consumers.
`
`Written submissions on the public
`interest must be filed no later than by
`close of business, eight calendar days
`after the date of publication of this
`notice in the Federal Register. There
`will be further opportunities for
`comment on the public interest after the
`issuance of any final initial
`determination in this investigation. Any
`written submissions on other issues
`
`must also be filed by no later than the
`close of business, eight calendar days
`after publication of this notice in the
`Federal Register. Complainant may file
`replies to any written submissions no
`later than three calendar days after the
`date on which any initial submissions
`were due. No other submissions will be
`
`accepted, unless requested by the
`Commission. Any submissions and
`replies filed in response to this Notice
`are limited to five (5) pages in length,
`inclusive of attachments.
`Persons filing written submissions
`must file the original document
`electronically on or before the deadlines
`stated above. Submissions should refer
`to the docket number (“Docket No.
`3545”) in a prominent place on the
`cover page and/or the first page. (See
`Handbook for Electronic Filing
`Procedures, Electronic Filing
`Procedures 1). Please note the
`Secretary’s Office will accept only
`electronic filings during this time.
`Filings must be made through the
`Commission’s Electronic Document
`
`Information System (EDIS, https://
`edis.usitc.gov.) No in—person paper-
`based filings or paper copies of any
`electronic filings will be accepted until
`further notice. Persons with questions
`regarding filing should contact the
`Secretary at EDISSHelp@usitc.gov.
`Any person desiring to submit a
`document to the Commission in
`
`confidence must request confidential
`treatment. All such requests should be
`directed to the Secretary to the
`Conunission and must include a full
`
`1 Handbook for Electronic Filing Procedures:
`https://www.usitc.gov/documents/handbook_on_
`filing_procedures.pdf.
`
`

`

`22070
`Federal Register/Vol. 86, No. 78/ Monday, April 26, 2021/Notices
`
`statement of the reasons why the
`Commission should grant such
`treatment. See 19 CFR 201.6. Documents
`
`for which confidential treatment by the
`Commission is properly sought will be
`treated accordingly. All information,
`including confidential business
`information and documents for which
`
`confidential treatment is properly
`sought, submitted to the Commission for
`purposes of this Investigation may be
`disclosed to and used: (i) By the
`Commission, its employees and Offices,
`and contract personnel (a) for
`developing or maintaining the records
`of this or a related proceeding, or (b) in
`internal investigations, audits, reviews,
`and evaluations relating to the
`programs, personnel, and operations of
`the Commission including under 5
`U.S.C. Appendix 3; or (ii) by U.S.
`government employees and contract
`personnel,z solely for cybersecurity
`purposes. All nonconfidential written
`submissions will be available for public
`inspection at the Office of the Secretary
`and on EDIS.3
`This action is taken under the
`
`authority of section 337 of the Tariff Act
`of 1930, as amended (19 U.S.C. 1337),
`and of §§ 201.10 and 210.8(c) of the
`Commission’s Rules of Practice and
`Procedure (19 CFR 201.10, 210.8(c)).
`By order of the Commission.
`Issued: April 21, 2021.
`Lisa Barton,
`Secretary to the Commission.
`[FR Doc. 2021—08654 Filed 4—23—21; 8:45 am]
`BILLING CODE 1020-024
`
`DEPARTMENT OF JUSTICE
`
`Drug Enforcement Administration
`
`[Docket No. DEA—827]
`
`Importer of Controlled Substances
`Application: Rhodes Technologies
`
`AGENCY: Drug Enforcement
`Administration, Department of Justice.
`
`ACTION: Notice of application.
`
`SUMMARY: Rhodes Technologies has
`applied to be registered as an importer
`of basic class(es) of controlled
`substance(s). Refer to Supplemental
`Information listed below for further
`
`drug information.
`DATES: Registered bulk manufacturers of
`the affected basic class(es), and
`applicants therefore, may file written
`comments on or objections to the
`
`2 All contract personnel will sign appropriate
`nondisclosure agreements.
`3 Electronic Document Information System
`(EDIS): https://edis.usitc.gov.
`
`issuance of the proposed registration on
`or before May 26, 2021. Such persons
`may also file a written request for a
`hearing on the application on or before
`May 26, 2021.
`ADDRESSES: Written comments should
`
`be sent to: Drug Enforcement
`Administration, Attention: DEA Federal
`Register Representative/DPW, 8701
`Morrissette Drive, Springfield, Virginia
`22152. All requests for a hearing must
`be sent to: Drug Enforcement
`Administration, Attn: Administrator,
`8701 Morrissette Drive, Springfield,
`Virginia 22152. All request for a hearing
`should also be sent to: (1) Drug
`Enforcement Administration, Attn:
`Hearing Clerk/OALJ, 8701 Morrissette
`Drive, Springfield, Virginia 22152; and
`(2) Drug Enforcement Administration,
`Attn: DEA Federal Register
`Representative/DPW, 8701 Morrissette
`Drive, Springfield, Virginia 22152.
`SUPPLEMENTARY INFORMATION: In
`accordance with 21 CFR 1301.34(a), this
`is notice that on March 15, 2021,
`Rhodes Technologies, 498 Washington
`Street, Coventry, Rhode Island 02816,
`applied to be registered as an importer
`of the following basic class(es) of
`controlled substance(s):
`
`Controlled substance
`
`Schedule
`
`|
`7370
`Tetrahydrocannabinols ..........
`||
`1 724
`Methylphenidate .................
`||
`9143
`Oxycodone .................
`||
`9150
`Hydromorphone
`.....
`||
`9193
`Hydrocodone ..............
`||
`9300
`Morphine ................
`
`||
`9600
`Opium, Raw ...........
`||
`9652
`Oxymorphone ........................
`
`
`9670Poppy Straw Concentrate ...... II
`
`
`
`The company plans to import Opium,
`Raw (9600), and Poppy Straw
`Concentrate (9670) in order to bulk
`manufacture controlled substances in
`
`Active Pharmaceutical Ingredient (API)
`form. The company distributes the
`manufactured APIs in bulk to its
`customers.
`
`The company plans to import the
`other listed controlled substances for
`
`internal reference standards use only.
`The comparisons of foreign reference
`standards to the company’s
`domestically manufactured API will
`allow the company to export
`domestically manufactured API to
`foreign markets.
`
`William T. McDermott,
`Assistant Administrator.
`[FR Doc. 2021—08539 Filed 4—23—21; 8:45 am]
`BILLING CODE 441 O—OS—P
`
`DEPARTMENT OF JUSTICE
`
`Drug Enforcement Administration
`
`[OMB Number 1117—NEW]
`
`Agency Information Collection
`Activities; Proposed eCollection,
`eComments Requested; New Proposed
`Collection Exempt Chemical
`Preparations Application
`
`AGENCY: Drug Enforcement
`Administration, Department of Justice.
`ACTION: 60-Day notice.
`
`SUMMARY: The Drug Enforcement
`Administration (DEA), Department of
`Justice (DOII, will be submitting the
`following information collection request
`to the Office of Management and Budget
`(OMB) for review and approval in
`accordance with the Paperwork
`Reduction Act of 1995.
`
`DATES: Comments are encouraged and
`will be accepted for 60 days until June
`25, 2021.
`FOR FURTHER INFORMATION CONTACT: If
`
`you have comments on the estimated
`public burden or associated response
`time, suggestions, or need a copy of the
`proposed information collection
`instrument with instructions or
`
`additional information, please contact
`Scott A. Brinks, Diversion Control
`Division, Drug Enforcement
`Administration; Mailing Address: 8701
`Morrissette Drive, Springfield, Virginia
`22152; Telephone: (571) 362—3261.
`SUPPLEMENTARY INFORMATION: Written
`
`comments and suggestions from the
`public and affected agencies concerning
`the proposed collection of information
`are encouraged. Your comments should
`address one or more of the following
`four points:
`—Evaluate whether the proposed
`collection of information is necessary
`for the proper performance of the
`functions of the agency, including
`whether the information will have
`
`practical utility;
`—Evaluate the accuracy of the agency’s
`estimate of the burden of the
`
`proposed collection of information,
`including the validity of the
`methodology and assumptions used;
`—Eva1uate whether and if so how the
`
`quality, utility, and clarity of the
`information proposed to be collected
`can be enhanced; and
`—Minimize the burden of the collection
`of information on those who are to
`
`respond, including through the use of
`appropriate automated, electronic,
`mechanical, or other forms of
`information technology, e.g.,
`permitting electronic submission of
`responses.
`
`